BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36834676)

  • 21. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
    Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
    Huang W; Zhu S; Liu Q; Li C; Li L
    Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells.
    Kantapan J; Paksee S; Duangya A; Sangthong P; Roytrakul S; Krobthong S; Suttana W; Dechsupa N
    BMC Complement Med Ther; 2021 Jul; 21(1):189. PubMed ID: 34217266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
    Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
    J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.
    Liu XF; Yang WT; Xu R; Liu JT; Zheng PS
    PLoS One; 2014; 9(1):e87092. PubMed ID: 24489842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-contact co-culture with human vascular endothelial cells promotes epithelial-to-mesenchymal transition of cervical cancer SiHa cells by activating the NOTCH1/LOX/SNAIL pathway.
    Ou J; Guan D; Yang Y
    Cell Mol Biol Lett; 2019; 24():39. PubMed ID: 31205475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.
    Salnikov AV; Liu L; Platen M; Gladkich J; Salnikova O; Ryschich E; Mattern J; Moldenhauer G; Werner J; Schemmer P; Büchler MW; Herr I
    PLoS One; 2012; 7(9):e46391. PubMed ID: 23050024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells.
    Kwon T; Bak Y; Ham SY; Yu DY; Yoon DY
    BMC Complement Altern Med; 2016 Feb; 16():42. PubMed ID: 26832364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
    Zhang F; Zhou Q
    Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Tyszka-Czochara M; Lasota M; Majka M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.
    Lu Y; Lu J; Li X; Zhu H; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
    BMC Cancer; 2014 Feb; 14():85. PubMed ID: 24521357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of E-cadherin induces cancer stem-cell-like phenotype and drug resistance in cervical cancer cells.
    Sharma A; Kaur H; De R; Srinivasan R; Pal A; Bhattacharyya S
    Biochem Cell Biol; 2021 Oct; 99(5):587-595. PubMed ID: 33677985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cancer stem cell-like properties and epithelial-to-mesenchymal transition in primary and secondary cancer cells.
    Lim W; Kim HE; Kim Y; Na R; Li X; Jeon S; Choi H; Kim O
    Int J Oncol; 2016 Sep; 49(3):991-1000. PubMed ID: 27315437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.